A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer's disease
Antioxidation and adjustable treatment strategies are critical for the effective treatment of Alzheimer's disease (AD). Here, we design a dual-targeted Prussian blue nanoformulation (PTCN) that can cross the blood-brain barrier and target amyloid beta aggregates further exert antioxidant effect...
Guardado en:
Autores principales: | Dongju Zhao, Yuqing Tang, Xinjun Suo, Chaonan Zhang, Yan Dou, Jin Chang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/075fcd76bbe94a41bff1b9118de1097e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanoformulations of natural products for management of metabolic syndrome
por: Taghipour YD, et al.
Publicado: (2019) -
Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective
por: Davatgaran-Taghipour Y, et al.
Publicado: (2017) -
Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
por: Qi Q, et al.
Publicado: (2017) -
Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy
por: Ramsha Aamir, et al.
Publicado: (2021) -
Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release
por: Shahein SA, et al.
Publicado: (2019)